The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Genetically modified poplar trees
- Startup Says It's Gene Hacked Trees to Suck Up More Climate-Destroying CO2
Faster Stronger From Iceland's Orca machine to CO2 vodka, scientists and innovators have been chasing affordable carbon capture technology — that is, tech that's able to soak up and reuse or otherwise ...
- This supercharged tree might help fight climate change
The startup says it's genetically modified hybrid poplar trees to grow faster so they'll absorb more carbon dioxide and help minimize the damage of climate change. Carbon dioxide has grown rapidly ...
- This supercharged tree might help fight climate change
The startup says it’s genetically modified hybrid poplar trees to grow faster so they’ll absorb more carbon dioxide and help minimize the damage of climate change. Carbon dioxide has grown ...
- This supercharged tree might help fight climate change
The problem with trees is that they are too slow. Part of the issue with catastrophic climate change is that, by some measures, an incredible amount of damage is already done. Even if all the coal ...
- This Startup's Modified Trees Grow Faster, Store More Carbon
Living Carbon has developed a technique to genetically modify trees that can grow faster, and store more carbon. According to a white paper published in February, its modified poplar trees stored ...
Go deeper with Google Headlines on:
Genetically modified poplar trees
Go deeper with Bing News on:
RNA interference
- Alnylam's Challenge: Scaling Up And Moving Beyond The Liver
Alnylam CEO Yvonne Greenstreet talks about what’s next for the company, including a transition into larger therapeutic areas and patient populations, and describes her own journey to the CEO role.
- Intellia: Slim Hopes Of Near-Term Commercial Revenue Makes Me Bearish
Intellia Therapeutics achieved a double-digit billion valuation last year. Check out what could create another sell-off in the NTLA stock next week.
- RNA Based Therapeutic Market Statistics 2021 – Top Impacting Factors that Can Win the Industry Globally
“RNA Based Therapeutic Market by Disease Type (RNA interference (RNAi) and RNA antisense), Application (Genetic Disorders and Auto Immune Disorders) and End User (Research Institutes, and ...
- Ribonucleic Acid (RNA) Interference Market Insights, Analysis, Segmentation, Opportunities, Historical Research, Analysis and Outlook by 2029
Ribonucleic Acid (RNA) Interference Market research report encompasses the study about the market potential for each geographical region based on the growth rate, macroeconomic parameters ...
- SLU and industry partners report the first effective drug to treat rare, genetic liver disease
Researchers at Saint Louis University's School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver ...